ALEBUND-B 09637Hong Kong Stock Exchange

26.3002.59%( -0.700 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
ALEBUND-B (09637) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Alebund Pharmaceuticals (Jiangsu) Limited
Market
HKEX Main Board
Listing Date
2026-06-29
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007QD0

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)35.83M103/112
Net Profit (Last FY)-879.54M116/125
ROE (Last FY)-149.04%114/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Gavin Guoyao Xia Executive Director
Jin Tian, M.D. Executive Director
Wang Yun Executive Director
Zhang Huading Executive Director
Lu An Non-Executive Director
Xu Runhong Independent Non-Executive Director
Zhui Chen Independent Non-Executive Director
Leung Chi Wai Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-26.

About this page

This page shows ALEBUND-B (09637) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.